Factors Affecting Smoking Resumption After Acute Coronary Syndromes

被引:0
|
作者
Vogiatzis, Ioannis [1 ]
Tsikrika, Evangelia [1 ]
Sachpekidis, Vasilios [1 ]
Pittas, Sarantis [1 ]
Kotsani, Athina [1 ]
机构
[1] Gen Hosp Veria, Dept Cardiol, Smoking Cessat Clin, Thessaloniki, Greece
关键词
Acute coronary syndromes; smoking cessation; dependency; smoking cessation clinics; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; MYOCARDIAL-INFARCTION; HEART-DISEASE; QUITTING SMOKING; BYPASS-SURGERY; CESSATION; INTERVENTION; PREDICTORS; MORTALITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Many patients who are hospitalised for acute ischaemic episodes stop smoking; however, many of them relapse and resume smoking again within three months from their hospitalisation. The aim of this study was to study the factors that might affect smoking resumption in patients who have suffered an acute coronary syndrome. Methods: We studied 420 patients, active smokers at the time of admission, who were hospitalised for an acute coronary episode. The patients' data (history, risk factors, smoking habits) were retrieved from their medical files. During their hospitalisation they were asked to stop smoking and to attend the smoking cessation clinic to be advised about this. The patients were followed for one year and logistic regression analysis was used to evaluate the independent predictors of smoking resumption and continuation. Results: Of the total patient population, 280 (66.67%) visited the smoking cessation clinic and followed a special programme. Most relapses were recorded during the first 3 months of follow up, after which time 223 (53.1%) were still smoking, compared with 256 (61.43%) at 1 year. Independent predictors of smoking resumption were: non-participation in the smoking cessation programme (odds ratio, OR: 4.32, p=0.0007); the use of antidepressants (OR: 2.28, p=0.01); a history of vascular disease (OR: 2.32, p=0.03); a history of chronic obstructive pulmonary disease (OR: 1.35, p=0.001; and a decree of nicotine dependency >8 on the Fagerstrom scale, as recorded in questionnaires (OR: 1.42, p=0.04). Conclusions: Smokers with acute coronary syndromes should be encouraged to participate in special secondary prevention programmes. Smoking cessation clinics contribute significantly to a reduction in smoking in this group of patients.
引用
下载
收藏
页码:294 / 300
页数:7
相关论文
共 50 条
  • [21] Antithrombotic Therapy after Acute Coronary Syndromes
    Parada Barcia, Jose
    Raposeiras Roubin, Sergio
    Abu-Assi, Emad
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19): : 1873 - 1873
  • [22] Lipid levels after acute coronary syndromes
    Pitt, Bertram
    Loscalzo, Joseph
    Ycas, Joseph
    Raichlen, Joel S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (15) : 1440 - 1445
  • [23] Resumption of Work After Acute Coronary Syndrome or Coronary Artery Bypass Graft Surgery
    Worcester, Marian U.
    Elliott, Peter C.
    Turner, Alyna
    Pereira, Jeremy J.
    Murphy, Barbara M.
    Le Grande, Michael R.
    Middleton, Katherine L.
    Navaratnam, Hema S.
    Nguyen, John K.
    Newman, Robert W.
    Tatoulis, James
    HEART LUNG AND CIRCULATION, 2014, 23 (05): : 444 - 453
  • [24] Impact of angina burden and other factors on treatment satisfaction after acute coronary syndromes
    Beinart, SC
    Sales, AE
    Spertus, JA
    Plomondon, ME
    Every, NR
    Rumsfeld, JS
    AMERICAN HEART JOURNAL, 2003, 146 (04) : 646 - 652
  • [25] Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes
    Chow, Clara K.
    Jolly, Sanjit
    Rao-Melacini, Purnima
    Fox, Keith A. A.
    Anand, Sonia S.
    Yusuf, Salim
    CIRCULATION, 2010, 121 (06) : 750 - 758
  • [26] Profile of the cardiovascular risk factors in acute coronary syndromes
    Abdelkbirane, C
    Haddani, S
    Mesbahi, Y
    El Messal, M
    Adlouni, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 2 - 2
  • [27] Cardiac rupture factors during acute coronary syndromes
    Juliard, Jean-Michel
    SANG THROMBOSE VAISSEAUX, 2010, 22 (08): : 397 - 398
  • [28] Role of thrombotic and fibrinolytic factors in acute coronary syndromes
    Saigo, M
    Hsue, PY
    Waters, DD
    PROGRESS IN CARDIOVASCULAR DISEASES, 2004, 46 (06) : 524 - 538
  • [29] Risk factors' management to impact on acute coronary syndromes
    Badimon, Lina
    Cubedo, Judit
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 217 : S7 - S9
  • [30] Advanced oxidation protein products affecting inflammation in acute coronary syndromes
    Fabbi, P.
    Fedele, M.
    Vercellino, M.
    Contini, P.
    Garibaldi, S.
    Bezante, G. P.
    Balbi, M.
    Indiveri, F.
    Barsotti, A.
    EUROPEAN HEART JOURNAL, 2009, 30 : 762 - 762